The "Natural" Aversion: The FDA's Reluctance To Define A Leading Food Industry Marketing Claim, And the Pressing Need For a Workable Rule

Home / News and Resources / The "Natural" Aversion: The FDA's Reluctance To Define A Leading Food Industry Marketing Claim, And the Pressing Need For a Workable Rule

Publications10/11/12

The “Natural” Aversion: The FDA’s Reluctance To Define A Leading Food Industry Marketing Claim, And the Pressing Need For a Workable Rule

Author(s): April Farris

First published in the Food & Drug Law Journal, 65, (2010)